FDA Promises Strong Safety Standards for Covid-19 Vaccines as It Convenes Advisory Panel - (The Wall Street Journal via NewsPoints Desk)

  • FDA officials renewed assurances Thursday during an advisory committee meeting that COVID-19 vaccines will undergo rigorous testing before being made widely available, reported The Wall Street Journal.

  • "Only those vaccines that are demonstrated to be safe and effective" will be licensed by the FDA, remarked Marion Gruber, director of the FDA's Office of Vaccines Research and Review.

  • Her comments came at the first meeting of the 25-member panel of medical experts, including specialists in fields like virology, infectious diseases and biostatistics. The group was established to make recommendations to the FDA on how best to assess the safety and effectiveness of vaccines.

  • FDA officials hope the panel hearing will help establish public trust in the safety and efficacy of a coronavirus vaccine, amid concerns of potential political influence in the process.

  • Agency officials recently issued a set of guidelines to govern how vaccine clinical trials will be conducted and evaluated, and have also formulated a set of tougher standards for the FDA to employ before granting an emergency-use authorization for a vaccine.

To read more NewsPoints articles, click here.